2010 Annual Meeting

The following presentations were given during the 2010 Annual Meeting, May 22-25, 2010 in Anaheim, CA.

Boards of Pharmacy and ACPE – Mining the Standards

During this non-continuing pharmacy education (CPE) pre-meeting special program, an expert panel will examine ways to harmonize standards for students educated in international, non-accredited programs of pharmacy with existing Accreditation Council for Pharmacy Education standards and boards of pharmacy requirements. 

• Jeffrey W. Wadelin, PhD, Associate Executive Director and Director, Professional Degree Program Accreditation, Accreditation Council for Pharmacy Education
  ACPE Accreditation and Foreign Graduates (PDF)
• Howard C. Anderson, Jr, RPh, Executive Director, North Dakota State Board of Pharmacy
  Apologetic for Harmonizing Standards for Students Educated in International, Non-accredited Programs of Pharmacy with Existing ACPE Standards and Board of Pharmacy Requirements (PDF) 
• Daniel Robinson, PharmD, FASHP, Dean and Professor of Pharmacy Practice, Western University of Health Sciences College of Pharmacy
  Introduction To International Post-Baccalaureate PharmD Program (PDF)

NABP Programs and Services Update

An NABP representative will provide participants with an update on some of the Association’s current and developing projects including the examination blueprint validation process, the Multistate Pharmacy Jurisprudence Examination® (MPJE®), and
recent survey of the MPJE Competency Statements, during this non-CPE special program. 

• Maria Boyle, MS, RPh, Competency Assessment Senior Manager, NABP
  Multistate Pharmacy Jurisprudence Examination^® (MPJE^®): Survey of the Revised MPJE Competency Statements

Protecting the Public Safety – Partnering CQI with Science

Everyone knows how important continuous quality improvement is to increasing safety. An expert in systems engineering will instruct meeting participants on how they can bring together safety science with the health care industry to minimize the risk of errors and provide quality outcomes. Attendees will also learn how North Carolina has already initiated changes to its health care system and how nurses are disciplined.

• John Westphal, BS, Human Factors Specialist/ Consultant, Outcome Engineering
  Building a Culture of Learning (PDF)
• Linda Burhans, RN, PhD, Associate Executive Director of Education and Practice, North Carolina Board of Nursing
  Improving Nursing Regulation: The “Just Culture” Approach (PDF) 

Learning Objectives

At the conclusion of this session, participants will be able to:

1. Describe how safety science minimizes the risk of errors and provides quality outcomes.
2. Explain how a variety of approaches to regulating health care professionals can help improve the overall system and increase patient safety.

State and Federal Agencies Protecting the Public – The National Practitioner Data Bank

Attendees will learn about the new reporting requirements mandated by recently enacted rulemaking provisions in Section 1921 of the Social Security Act that now require each state to adopt a system of reporting certain adverse licensure actions taken against health care practitioners, including pharmacists. 

• Shari W. Campbell, DPM, MSHS‚ Acting Chief of the Policy and Research Branch, Division of Practitioner Data Banks, Bureau of Health Professions‚ Health Resources and Services Administration, United States Department of Health and Human Services
  State and Federal Agencies Protecting the Public: The National Practitioner Data Bank (PDF)

Learning Objectives

At the conclusion of this session, participants will be able to:

1. Explain the new reporting requirements mandated by Section 1921 of the Social Security Act.
2. Describe how a board of pharmacy’s reporting system to the National Practitioner Data Bank must operate.

Protecting Against Cargo Theft – Agencies and Industries Partner Together

Much like the stage coaches heading off to the gold rush required protection against bandits, so does today’s cargo that transports much of our nation’s drugs, devices, and infant formula. Cargo thefts are on the rise and attendees will participate in a panel presentation to discuss how to curb this troubling trend.

• Chuck Forsaith, BS, Corporate Director, Supply Chain Security, Purdue Pharma L.P.
  Presentation not available 
• William Harvey, MBA, RPh, Executive Director/Chief Drug Inspector, New Mexico Board of Pharmacy
  New Mexico Board of Pharmacy (PDF)
• Ilisa B.G. Bernstein, PharmD, JD, Deputy Director (Acting), Office of Compliance, Center for Drug Evaluation and Research, Food and Drug Administration
  Cargo Theft: FDA Perspective (PDF) 

Learning Objectives

At the conclusion of this session, participants will be able to:

1. Describe the frequency and demographics of medication cargo thefts.
2. Explain the methods that can be utilized to decrease the incidence of cargo thefts.

The Controlled Substances Act – A New Frontier

It is no secret that the Controlled Substances Act requires revising. A Drug Enforcement Administration representative and board of pharmacy representative will provide an overview including the current issues, areas of concern, and what changes would benefit
health care practitioners and patients alike.

• Michael Lewis, BS, Diversion Program Manager, Drug Enforcement Administration
  DEA Update on Regulations and Enforcement (PDF)
• Jay Campbell IV, RPh, JD, Executive Director, North Carolina Board of Pharmacy
  The Controlled Substances Act – A New Frontier (PDF)

Learning Objectives

At the conclusion of this session, participants will be able to:

1. Describe the current status and possible changes to the federal Controlled Substances Act.
2. Explain how changes to the federal Controlled Substances Act will benefit patients and affect the practices of health care practitioners.